Six months on: What more do we know about COX-2 inhibitors and the risk of adverse cardiovascular events?

---

Autoria(s): Robinson, M. T.

Contribuinte(s)	K. Ross
Data(s)	01/01/2005
Identificador	http://espace.library.uq.edu.au/view/UQ:77608
Publicador	Gold Cross Products
Palavras-Chave	#CX #320501 Pharmaceutical Sciences and Pharmacy #730301 Health education and promotion
Tipo	Journal Article